Be Aware of Gallbladder, Biliary Disease With Newer Obesity Drugs

Physicians and patients should be aware of potential for gallbladder or biliary diseases with GLP-1 agonists, especially in high doses used for weight loss, meta-analysis authors conclude.
Medscape Medical News

source https://www.medscape.com/viewarticle/970999?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost